Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)
- Status
- COMPLETED
- Phase
- PHASE2
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Assessment of Long-Term Infliximab for Psoriasis (P05319)
- Status
- COMPLETED
- Phase
- N/A
A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
- Status
- COMPLETED
- Phase
- N/A
Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
- Status
- COMPLETED
- Phase
- N/A
Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
- Status
- TERMINATED
- Phase
- PHASE3